Insurances & Business

Analysts Mixed on Takeda’s $8.8 Billion Millennium Buy

Investment | Sources: bnet.com

Similar/Related/News:

• Takeda says to buy Millennium Pharma for $8.8 billion (Reuters)
Takeda Pharmaceutical Co Ltd said it would buy U.S. firm Millennium Pharmaceuticals Inc for $8.8 billion to boost its cancer drug business, in the big...
• Takeda Says to Buy Millennium Pharma For $8.8 Billion
TOKYO (Reuters) - Takeda Pharmaceutical Co Ltd <4502.T> said it would buy U.S. firm Millennium Pharmaceuticals Inc <MLNM.O> for $8.8 b...
• Analysts See Big Q2 Writedowns For Citi, Merrill
(Reuters) - Citigroup Inc <C.N> may write down $8.7 billion and Merrill Lynch & Co Inc <MER.N> $4.5 billion in the second quarter,...
• Sector snap: Airline stocks mixed (AP)
Airline shares traded mixed Monday as the broader market rallied and oil prices wavered following a sharp run-up last week....
• Sector roundup: Web companies, truckers (AP)
Shares of major Internet companies mostly fell Thursday, with eBay Inc. declining as analysts' expressed mixed reactions to the online auctioneer's 22...
• ADRs in Focus: Latin American ADRs mixed (AP)
Shares of Latin American companies that trade on U.S. markets were mixed on Monday, as Peru's Compania de Minas Buenaventura gained and Mexico's Grupo...
• Stocks end mixed after companies turn in uneven results (AP)
Wall Street finished an erratic session mixed Thursday after an uneven batch of earnings reports made investors cautious about buying stocks. Disappoi...
• Anheuser-Busch Sees Profit Above Analysts’ View
CHICAGO (Reuters) - Anheuser-Busch Cos Inc <BUD.N> on Friday forecast 2008 earnings above analysts' estimates as it laid out a cost-cutting ...